Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: Report of a unique case successfully treated with Temozolomide

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 267-270

  Michotte, A ^a   Chaskis, C ^a   Sadones, J ^a   Veld, P In't ^a   Neyns, B ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

1p36 19q13 deletion; FISH; Long survival; Primary leptomeningeal anaplastic oligodendroglioma; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN DAMAGE; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; OLIGODENDROGLIOMA; PARIETAL LOBE; PRIMARY LEPTOMENINGEAL ANAPLASTIC OLIGODENDROGLIOMA; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS, ALKYLATING; ARACHNOID; BRAIN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DACARBAZINE; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL CARCINOMATOSIS; MENINGEAL NEOPLASMS; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; OLIGODENDROGLIOMA; PIA MATER; RADIOTHERAPY; SPINAL CORD; SUBARACHNOID SPACE; TREATMENT OUTCOME;

EID: 70350620986     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.047     Document Type: Article

References (16)

1. Cooper I.S., and Kernohan J.W. Heterotopic glial nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas. J Neuropathol Exp Neurol 10 1 (1951) 16-29
2. Ko M.W., et al. Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis. J Neurol Sci 278 (2009) 127-131
3. Chen R., Macdonald D.R., and Ramsay D.A. Primary diffuse leptomeningeal oligodendroglioma. Case report. J Neurosurg 83 (1995) 724-728
4. Beck D.J.K., and Russell D.S. Oligodendrogliomatosis of the cerebrospinal pathway. Brain 65 (1942) 352-372
5. Korein J., Feigin I., and Shapiro M.F. Oligodendrogliomatosis with intracranial hypertension. Neurology 7 (1957) 589-594
6. Rogers L.R., Estes M., Rosenbloom S.A., and Leslie H. Primary leptomeningeal oligodendroglioma: a case report. Neurosurgery 36 (1995) 166-169
7. Ng H.K., and Poon W.S. Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31 (1999) 59-63
8. Pradat P.F., Hoang-Xuan K., Cornu P., Mokhtari K., Martin-Duverneuil N., Poisson M., and Delattre J.Y. Treatment of meningeal gliomatosis. J Neurooncol 44 (1999) 163-168
9. Armao D.M., Stone J., Castillo M., Mitchell K.M., Bouldin T.W., and Suzuki K. Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21 (2000) 1122-1126
10. Bourne T.D., Mandell J.W., Matsumoto J.A., Jane J.A., and Lopes B.S. Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report. J Neurosurg 105 (2006) 465-469
11. Ozkul A., Meteoglu I., Tataroglu C., and Akyol A. Primary diffuse leptomeningeal oligodendrogliomatosis causing sudden death. J Neurooncol 81 (2007) 75-79
12. Yomo S., Tada T., Hirayama S., Tachibana N., Otani M., Tanaka Y., and Hong K. A case report and review of the literature. J Neurooncol 81 (2007) 209-216
13. Debono B., Derrey S., Rabehenoina C., Proust F., and Freger P. Laquerrière A. Primary diffuse multinodular leptomeningeal gliomatosis. Case report and review of the literature. Surgical Neurology 65 (2006) 273-282
14. Beauchesne P., Pialat J., Duthel R., Barral F.G., Clavreul G., Schmitt T., and Laurent B. Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis. A case report. J Neurooncol 37 (1998) 161-167
15. Franceschi E., Cavallo G., Scopece L., Esposti R.D., Paioli G., Paioli A., et al. Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis. J Neurooncol 73 (2005) 261-264
16. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., Silver J.S., Stark P.C., Macdonald D.R., Ino Y., Ramsay D.A., and Louis D.N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90 (1998) 1473-1479